WASHINGTON (AP) — A federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company.
The three-judge panel said a lower court misinterpreted the company's patent and should not have ruled in favor of Bruce Saffran, a doctor from Princeton, N.J.
Heart stents are mesh-wire tubes that prop open arteries affected by coronary artery disease. The dispute centered over drug-eluting stents, which release a drug to help keep arteries from clogging.
Saffran sued J&J in 2007 saying its Cypher stents infringed on his 1997 patent covering technology to deliver medication inside the body. A Texas jury ruled in Saffran's favor in 2011, concluding J&J had willfully infringed on his patent.
George Soros: Top 10 Reasons He Is Dangerous | Human Events
Report: Hillary's Wall Street Speech Transcripts Would 'Bury Her'
The Biggest Winner from New Hampshire Was Hillary Clinton | RedState
'Worth a thousand words': One 'disgraceful' photo sums up Hillary perfectly
Open thread: The battle for New Hampshire’s silver medal; Update: Fox calls Trump, Sanders winners; Update: Fox, ABC, NBC call silver for Kasich
After Youtube Terminated His Account Twice, Hickok45 Found A New Home
Low Oil Prices to Stay with us for a Decade?